Elanco Animal Health Incorporated (ETR:5EA)
Germany · Delayed Price · Currency is EUR 20.06
0.00 (0.00%)
Inactive · Last trade price on Mar 16, 2026
Elanco Animal Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 428 | 545 | 468 | 352 | 345 | 638 |
Cash & Short-Term Investments | 428 | 545 | 468 | 352 | 345 | 638 |
Cash Growth | -12.12% | 16.45% | 32.95% | 2.03% | -45.92% | 28.89% |
Accounts Receivable | 1,084 | 873 | 805 | 842 | 797 | 833 |
Other Receivables | 70 | 67 | 81 | 168 | 205 | 195 |
Total Trade Receivables | 1,154 | 940 | 886 | 1,010 | 1,002 | 1,028 |
Inventory | 1,717 | 1,737 | 1,574 | 1,735 | 1,538 | 1,371 |
Other Current Assets | 285 | 236 | 287 | 310 | 394 | 237 |
Total Current Assets | 3,584 | 3,458 | 3,215 | 3,407 | 3,279 | 3,274 |
Net Property, Plant & Equipment | 1,395 | 1,409 | 993 | 1,026 | 999 | 1,055 |
Other Intangible Assets | 3,225 | 3,408 | 3,681 | 4,494 | 4,842 | 5,587 |
Goodwill | 4,723 | 4,779 | 4,414 | 5,094 | 5,993 | 6,172 |
Other Long-Term Assets | 295 | 304 | 311 | 341 | 378 | 390 |
Total Assets | 13,222 | 13,358 | 12,614 | 14,362 | 15,491 | 16,478 |
Accounts Payable | 372 | 368 | 296 | 270 | 390 | 416 |
Accrued Expenses | 400 | 622 | 509 | 524 | 470 | 504 |
Current Portion of Long-Term Debt | 73 | 74 | 44 | 38 | 388 | 294 |
Other Current Liabilities | 817 | 533 | 466 | 409 | 454 | 433 |
Total Current Liabilities | 1,662 | 1,597 | 1,315 | 1,241 | 1,702 | 1,647 |
Long-Term Debt | 3,918 | 3,943 | 4,277 | 5,736 | 5,448 | 6,025 |
Other Long-Term Liabilities | 1,142 | 1,271 | 926 | 1,162 | 1,052 | 1,298 |
Total Long-Term Liabilities | 5,060 | 5,214 | 5,203 | 6,898 | 6,500 | 7,323 |
Total Liabilities | 6,722 | 6,811 | 6,518 | 8,139 | 8,202 | 8,970 |
Additional Paid-in Capital | 8,858 | 8,870 | 8,817 | 8,777 | 8,738 | 8,696 |
Accumulated Other Comprehensive Income | -233 | -141 | -771 | -266 | -392 | -209 |
Retained Earnings | -2,125 | -2,182 | -1,950 | -2,288 | -1,057 | -979 |
Shareholders' Equity | 6,500 | 6,547 | 6,096 | 6,223 | 7,289 | 7,508 |
Total Liabilities & Equity | 13,222 | 13,358 | 12,614 | 14,362 | 15,491 | 16,478 |
Total Debt | 3,991 | 4,017 | 4,321 | 5,774 | 5,836 | 6,319 |
Net Cash (Debt) | -3,563 | -3,472 | -3,853 | -5,422 | -5,491 | -5,681 |
Net Cash Per Share | -7.13 | -6.99 | -7.75 | -11.01 | -11.24 | -11.66 |
Book Value | 6,500 | 6,547 | 6,096 | 6,223 | 7,289 | 7,508 |
Book Value Per Share | 13.00 | 13.19 | 12.26 | 12.64 | 14.93 | 15.41 |
Tangible Book Value | -1,448 | -1,640 | -1,999 | -3,365 | -3,546 | -4,251 |
Tangible Book Value Per Share | -2.90 | -3.30 | -4.02 | -6.84 | -7.26 | -8.73 |